➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Moodys
McKesson
McKinsey
Mallinckrodt

Last Updated: October 23, 2021

DrugPatentWatch Database Preview

Litigation Details for Keryx Biopharmaceuticals, Inc. v. Lupin Ltd. (D. Del. 2018)


Email this page to a colleague

« Back to Dashboard

Keryx Biopharmaceuticals, Inc. v. Lupin Ltd. (D. Del. 2018)

Docket ⤷  Try it Free Date Filed 2018-12-12
Court District Court, D. Delaware Date Terminated 2020-10-05
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties KERYX BIOPHARMACEUTICALS, INC.
Patents 7,767,851; 8,093,423; 8,299,298; 8,338,642; 8,609,896; 8,754,257; 8,754,258; 8,846,976; 8,901,349; 9,050,316; 9,328,133; 9,387,191; 9,757,416
Attorneys Tara Mythri Raghavan
Firms Phillips, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Keryx Biopharmaceuticals, Inc. v. Lupin Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Try it Free .

Details for Keryx Biopharmaceuticals, Inc. v. Lupin Ltd. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-12-12 1 United States Patent Nos. 5,753,706 (the “’706 patent”); 7,767,851 (the “’851 patent”); 8,093,423 (the…(the “’423 patent”); 8,299,298 (the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896…’896 patent”); 8,754,257 (the “’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent…,349 (the “’349 patent”); 9,050,316 (the “’316 patent”); 9,328,133 (the “’133 patent”); 9,757,416 (the… #: 2 “’416 patent”); and 9,387,191 (the “’191 patent”) (collectively, the “patents-in-suit”), owned External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
AstraZeneca
McKesson
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.